TMEM18 and obesity disorder: In the inflammatory state of obesity, TMEM18 downregulation reduces PPARG1 levels, contributing to the metabolic dysregulation, adipocyte hypertrophy, adiponectin reduction, impaired glucose, and lipid metabolism and obesity aggravation [155].